Announcements Trials
Browse Landscape

Status

Recruiting 2

Sponsor Class

OTHER 143INDUSTRY 34NIH 13NETWORK 13OTHER_GOV 2

Study Type

Interventional 5Observational 2

Sponsor

Cancer Type

Genitourinary 2Thoracic 1Gastrointestinal 1

Conditions

Neoplasms 72Breast Neoplasms 71Colorectal Neoplasms 42Prostatic Neoplasms 35Lung Neoplasms 30Stomach Neoplasms 27Uterine Cervical Neoplasms 25Carcinoma, Non-Small-Cell Lung 22Endometrial Neoplasms 20Ovarian Neoplasms 19Carcinoma, Hepatocellular 19Rectal Neoplasms 18Thyroid Neoplasms 16Colonic Neoplasms 16Urinary Bladder Neoplasms 15Precursor Cell Lymphoblastic Leukemia-Lymphoma 15Pancreatic Neoplasms 15Esophageal Neoplasms 14Multiple Myeloma 12Gastrointestinal Neoplasms 11Recurrence 10Neoplasm Metastasis 10Sarcopenia 9Obesity 9Leukemia, Myeloid, Acute 9Disease 9Thyroid Cancer, Papillary 8Polycystic Ovary Syndrome 8Melanoma 8Lymphoma 8

Interventions

Cytological Techniques 1Cystoscopy 1Blood Cell Count 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER_GOV × Observational × Kidney Neoplasms × Clear all
NCT07485114 2026-03-20

Association Between Galectin-3 Levels and Outcomes in Patients With Renal Cell Carcinoma, Transitional Cell Carcinoma , Non Small Cell Lung Cancer, and Hepatocellular Carcinoma, Treated With PD-1/PDL-1 Inhibitors

Tel-Aviv Sourasky Medical Center

Recruiting
300 enrolled
GastrointestinalGenitourinaryThoracic

Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Transitional Cell, Carcinoma, Hepatocellular, Kidney Neoplasms

NCT07037589 2025-11-21

BLUSH

Vastra Gotaland Region

Recruiting
300 enrolled
Genitourinary

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell, Hematuria, Kidney Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡